The focus meeting will be held as a digital conference on November 24.
A virus the size of a few nanometers paralyzes the whole world. Biotech companies and pharmaceutical companies are working flat out to develop a vaccine against the new coronavirus Sars-CoV-2, driven by funds and the expectations of governments worldwide. With the event “Corona Vaccine – Impact of Nanotechnology” organized by NINa SH we would like to inform you about current activities and research from science and industry in the cross-sectional area of biotechnology and nanotechnology in vaccine development.
The presentations are each 25 minutes long. Subsequently the participants have the opportunity to ask questions.
Participation is free of charge, registration is required.
Date: 24 November 2020, Time: 2 pm
Prof. Dr. Franz Faupel,
Chair for Multicomponent Materials, Kiel University /
Chairman North German Initiative Nanotechnology Schleswig-Holstein e.V.
Vaccine development – what is nano in it?
Prof. Dr. Regina Scherließ,
Pharmaceutical Institute, Kiel University /
North German Initiative Nanotechnology Schleswig-Holstein e.V.
Challenges in Engineering Therapeutic Antibodies
Prof. Dr. Matthias Peipp,
Section for stem cell- and immunotherapy, UKSH
Detection of SARS-CoV-2 infections using a combination of virus and antibody analysis on a point-of-care biochip platform
Covid-19, microbial manufacturing options for vaccines and treatments
Dr. Thilo Kamphausen,
Richter-Helm BioLogics GmbH & Co. KG
Wrap up and Closing
Dr. Christian Ohrt, NINa SH
Telefon: +49 431 880-6245